• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    DuPont Reports First Quarter 2025 Results

    5/2/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    • Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago period
    • GAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 million
    • GAAP EPS from continuing operations of $(1.33); adjusted EPS of $1.03
    • Cash provided by operating activities from continuing operations of $382 million; transaction-adjusted free cash flow of $212 million
    • Maintaining full year 2025 financial guidance; separately providing tariff impact sensitivity

    WILMINGTON, Del., May 2, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the first quarter ended March 31, 2025.

    DuPont Logo (PRNewsfoto/DuPont)

    "Our results reflect continued strong quarterly financial performance with year-over-year organic sales growth and margin expansion in both the ElectronicsCo and IndustrialsCo segments," said Lori Koch, DuPont Chief Executive Officer. "We continue to benefit from ongoing strength in electronics markets as well as strong demand in healthcare and water end-markets. Through April, we continued to see strong order patterns consistent with our expectations."

    "Our global manufacturing footprint and flexible supply chain network serves us well as we manage through the impact of tariffs," Koch continued. "Our teams are actively engaged with customers and suppliers as we work to further mitigate the impact."

    "We remain on track for a November 1, 2025 spin-off of the Electronics business, which was announced this week as Qnity. We continue to achieve key milestones related to the separation, including executive leadership and Board appointments, as well as last week's filing of the initial Form 10 registration statement with the SEC," Koch concluded.

    First Quarter 2025 Consolidated Results(1)



     

    Dollars in millions, unless noted

     

    1Q'25

     

    1Q'24

    Change

    vs. 1Q'24

    Organic Sales (2)

    vs. 1Q'24

    Net sales

    $3,066

    $2,931

    5 %

    6 %

    GAAP (Loss)/Income from continuing operations

    $(548)

    $183

    (399) %



    Operating EBITDA(2)

    $788

    $682

    16 %



    Operating EBITDA margin(2) %

    25.7 %

    23.3 %

    240 bps



    GAAP EPS from continuing operations

    $(1.33)

    $0.41

    (424) %



    Adjusted EPS(2)

    $1.03

    $0.79

    30 %



    Cash provided by operating activities – cont. ops.

    $382

    $493

    (23) %



    Transaction-adjusted free cash flow(2)

    $212

    $286

    (26) %



    Net sales

    • Net sales increased 5% on organic sales growth of 6% partially offset by a currency headwind of 1%.
    • Organic sales growth of 6% consisted of an 8% increase in volume partially offset by a 2% decrease in price.
      • Higher volume was driven by double-digit gains in electronics, healthcare and water end-markets.
    • 14% organic sales growth in ElectronicsCo; 2% organic sales growth in IndustrialsCo.
    • 13% organic sales growth in Asia Pacific; 4% organic sales growth in EMEA; flat organic sales growth in U.S. & Canada.

    GAAP Loss/Loss per share from continuing operations

    • The GAAP Loss/Loss per share from continuing operations during the quarter was driven by a $768 million non-cash goodwill impairment charge related to the Aramids reporting unit.



      In connection with the 2025 Segment Realignment(3), DuPont was required to perform specific impairment analyses as a result of redefining certain reporting units along with the reallocation of goodwill. As part of these steps, the Aramids business (Nomex® and Kevlar®) was identified as a new standalone reporting unit (Aramids was previously part of the Protection reporting unit which consisted of the prior Safety Solutions and Shelter Solutions lines of business). The carrying value of the Aramids reporting unit consists of historical DuPont assets and liabilities that were measured at fair value in connection with the merger between Dow and DuPont, including the step-up of goodwill and intangible asset balances. Based on this analysis, DuPont recorded a goodwill impairment charge.

    Operating EBITDA

    • Operating EBITDA increased as volume benefits and savings from restructuring actions were partially offset by growth investments.

    Adjusted EPS

    • Adjusted EPS increased due primarily to higher segment earnings.

    Cash provided by operating activities from continuing operations

    • Cash provided by operating activities from continuing operations in the quarter of $382 million, capital expenditures of $249 million and separation transaction cost payments of $79 million resulted in transaction-adjusted free cash flow and related conversion of $212 million and 49%, respectively.

    (1) Results and cash flows are presented on a continuing operations basis. See pages 6-7 for further information, including the basis of presentation included in this release.

    (2) Organic sales, operating EBITDA, operating EBITDA margin, adjusted EPS, transaction-adjusted free cash flow and transaction-adjusted free cash flow conversion are non-GAAP measures and only reflect continuing operations. See pages 6-7 for further discussion, including a definition of significant items. Reconciliation to the most directly comparable GAAP measure, including details of significant items on page 13 of this communication.

    (3) Effective in the first quarter of 2025, in light of the Intended Electronics Separation, the Company realigned its management and reporting structure which resulted in a change in reportable segments and lines of business (2025 Segment Realignment). Results for historical periods have been recast to conform to the new structure.  Refer to page 5 for additional information.

     

    First Quarter 2025 Segment Highlights



    ElectronicsCo(3)

     

    Dollars in millions, unless noted

     

    1Q'25

     

    1Q'24

    Change

    vs. 1Q'24

    Organic Sales(2)

    vs. 1Q'24

    Net sales

    $1,118

    $984

    14 %

    14 %

    Operating EBITDA

    $373

    $295

    26 %



    Operating EBITDA margin %

    33.4 %

    30.0 %

    340 bps



    Net sales

    • Net sales and organic sales increased 14% as a 16% increase in volume was partially offset by a 2% decrease in price.
      • Semiconductor Technologies sales up low double-digits on an organic basis on strong end-market demand, driven primarily by advanced nodes and AI technology applications, along with strong China volume.
      • Interconnect Solutions sales up high-teens on an organic basis reflecting continued broad-based demand, content and share gains, and volume benefits from AI-driven technology ramps.

    Operating EBITDA

    • Operating EBITDA increased as volume benefits were partially offset by growth investments.
    • Operating EBITDA margin of 33.4% increased 340 basis points.

    IndustrialsCo(3)

     

    Dollars in millions, unless noted

     

    1Q'25

     

    1Q'24

    Change

    vs. 1Q'24

    Organic Sales(2)

    vs. 1Q'24

    Net sales

    $1,948

    $1,947

    — %

    2 %

    Operating EBITDA

    $464

    $439

    6 %



    Operating EBITDA margin %

    23.8 %

    22.5 %

    130 bps



    Net sales

    • Net sales were flat as organic sales growth of 2% was offset by a currency headwind of 1% and unfavorable portfolio impact of 1%.
      • Healthcare & Water Technologies sales up low-teens on an organic basis reflects volume growth in all business lines within Healthcare and demand strength in Water led by reverse osmosis.
      • Diversified Industrials sales down mid-single digits on an organic basis due primarily to softness in construction and auto markets.

    Operating EBITDA

    • Operating EBITDA increased due to volume benefits and savings from restructuring actions.
    • Operating EBITDA margin of 23.8% increased 130 basis points.

    Financial Outlook



    Dollars in millions, unless noted

    2Q'25E

    Full Year 2025E*

    Net sales

    ~$3,200

    $12,800 - $12,900

    Operating EBITDA(2)

    ~$815

    $3,325 - $3,375

    Adjusted EPS(2)

    ~$1.05

    $4.30 - $4.40

     * Does not include an expected net cost impact from announced tariffs currently estimated at ~$60 million (or ~$0.10 per share).

    "For the second quarter of 2025, we estimate net sales of about $3.2 billion, operating EBITDA of about $815 million and adjusted EPS of approximately $1.05 per share," said Antonella Franzen, DuPont Chief Financial Officer. "Our second quarter guidance includes a seasonal sequential sales lift, although muted from prior expectations given timing shifts from the second quarter into the first quarter in Semiconductor Technologies."

    "Our full year 2025 guidance remains unchanged from our prior outlook. Further, full year guidance does not include a net cost impact of announced tariffs currently estimated at $60 million, or about $0.10 per share," Franzen concluded. 

    Conference Call

    The Company will host a live webcast of its quarterly earnings conference call with investors to discuss its results and business outlook beginning today at 8:00 a.m. ET. The slide presentation that accompanies the conference call will be posted on the DuPont's Investor Relations Events and Presentations page. A replay of the webcast also will be available on the DuPont's Investor Relations Events and Presentations page following the live event.

    About DuPont

    DuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

    DuPontTM and all products, unless otherwise noted, denoted with TM, SM or ® are trademarks, service marks or registered trademarks of affiliates of DuPont de Nemours, Inc.

    Overview

    On January 15, 2025, DuPont de Nemours, Inc. ("DuPont", or after the completion of the Intended Electronics Separation, "New DuPont") announced it is targeting November 1, 2025 to complete the intended separation of its Electronics business (the "Intended Electronics Separation") by way of a spin-off transaction, thereby creating a new independent, publicly traded electronics company ("ElectronicsCo").

    The Intended Electronics Separation will not require a shareholder vote and is subject to satisfaction of customary conditions, including final approval by DuPont's Board of Directors, receipt of tax opinion from counsel, the completion and effectiveness of the  Form 10 registration statement filed with the U.S. Securities and Exchange Commission, applicable regulatory approvals and satisfactory completion of financing.

    Effective in the first quarter of 2025, in light of the Intended Electronics Separation, the Company realigned its management and reporting structure. This realignment resulted in a change in reportable segments in the first quarter of 2025 which changed the manner in which the Company reports financial results by segment, (the "2025 Segment Realignment"). As a result, commencing with the first quarter of 2025, the businesses to be separated as part of the Intended Electronics Separation are reported separately from the other businesses of DuPont. The discussion of results, including the financial measures further discussed below, are reflective of the new two segment reporting structure as described below:

    • ElectronicsCo includes the businesses within the Semiconductor Technologies and Interconnect Solutions lines of business, as well as the electronics-related product lines previously within Industrial Solutions, including electronics polymers and perfluoroeasltomer materials and parts (Kalrez®).
    • IndustrialsCo includes the businesses within the former Water & Protection segment, the healthcare and non-electronics businesses, including Vespel® parts and shapes, previously in Industrial Solutions and the Auto Adhesives & Fluids, MultibaseTM and Tedlar® businesses, previously within Corporate & Other.

    Cautionary Statement about Forward-looking Statements

    This document contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target, "outlook," "stabilization," "confident," "preliminary," "initial," and similar expressions and variations or negatives of these words. All statements, other than statements of historical fact, are forward-looking statements, including statements regarding outlook, expectations and guidance, including with respect to the potential impact of tariffs and discussion of trade sensitivity and macroeconomic uncertainties.  Forward-looking statements address matters that are, to varying degrees, uncertain and subject to risks, uncertainties, and assumptions, many of which that are beyond DuPont's control, that could cause actual results to differ materially from those expressed in any forward-looking statements.

    Forward-looking statements are not guarantees of future results. Some of the important factors that could cause DuPont's actual results to differ materially from those projected in any such forward-looking statements include, but are not limited to: (i) the ability of DuPont to effect the Intended Electronics Separation and to meet the conditions related thereto; (ii) the possibility that the Intended Electronics Separation will not be completed within the anticipated time period or at all; (iii) the possibility that the Intended Electronics Separation will not achieve its intended benefits; (iv) the impact of Intended Electronics Separation on DuPont's businesses and the risk that the separation may be more difficult, time-consuming or costly than expected, including the impact on DuPont's resources, systems, procedures and controls, diversion of management's attention and the impact and possible disruption of existing relationships with customers, suppliers, employees and other business counterparties; (v) the possibility of disruption, including disputes, litigation or unanticipated costs, in connection with the Intended Electronics Separation; (vi) the uncertainty of the expected financial performance of DuPont or the separated company following completion of the Intended Electronics Separation; (vii) negative effects of the announcement or pendency of the Intended Electronics Separation on the market price of DuPont's securities and/or on the financial performance of DuPont; (viii) the ability to achieve anticipated capital structures in connection with Intended Electronics Separation, including the future availability of credit and factors that may affect such availability; (ix) the ability to achieve anticipated credit ratings in connection with the Intended Electronics Separation; (x) the ability to achieve anticipated tax treatments in connection with the Intended Electronics Separation and completed and future, if any, divestitures, mergers, acquisitions and other portfolio changes and the impact of changes in relevant tax and other laws; (xi) risks and costs related to each of the parties respective performance under and the impact of the arrangement to share future eligible PFAS costs by and among DuPont, Corteva and Chemours, including the outcome of any pending or future litigation related to PFAS or PFOA, including personal injury claims and natural resource damages claims; the extent and cost of ongoing remediation obligations and potential future remediation obligations; and changes in laws and regulations applicable to PFAS chemicals; (xii) indemnification of certain legacy liabilities; (xiii) the failure to realize expected benefits and effectively manage and achieve anticipated synergies and operational efficiencies in connection with the Intended Electronics Separation and completed and future, if any, divestitures, mergers, acquisitions, and other portfolio management, productivity and infrastructure actions; (xiv) the risks and uncertainties, including increased costs and the ability to obtain raw materials and meet customer needs from, among other events, pandemics and responsive actions; (xv) adverse changes in worldwide economic, political, regulatory, international trade, geopolitical, capital markets and other external conditions; and other factors beyond DuPont's control, including inflation, recession, military conflicts, natural and other disasters or weather-related events, that impact the operations of DuPont, its customers and/or its suppliers; (xvi) the ability to offset increases in cost of inputs, including raw materials, energy and logistics; (xvii) the risks associated with continuing or expanding trade disputes or restrictions and responsive actions, new or increased tariffs or export controls including on exports to China of U.S.-regulated products and technology, and the significant uncertainties related thereto; (xviii) the risks, including ability to achieve, and costs associated with DuPont's sustainability strategy, including the actual conduct of DuPont's activities and results thereof, and the development, implementation, achievement or continuation of any goal, program, policy or initiative discussed or expected; (xix) other risks to DuPont's business and operations, including the risk of impairment; and (xx) other risk factors discussed in DuPont's most recent annual report and subsequent current and periodic reports filed with the U.S. Securities and Exchange Commission. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business or supply chain disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont's consolidated financial condition, results of operations, credit rating or liquidity. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. DuPont assumes no obligation to publicly provide revisions or updates to any forward-looking statements whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

    Non-GAAP Financial Measures

    Unless otherwise indicated, all financial metrics presented reflect continuing operations only.

    This communication includes information that does not conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") and are considered non-GAAP measures. Management uses these measures internally for planning, forecasting and evaluating the performance of the Company, including allocating resources. DuPont's management believes these non-GAAP financial measures are useful to investors because they provide additional information related to the ongoing performance of DuPont to offer a more meaningful comparison related to future results of operations. These non-GAAP financial measures supplement disclosures prepared in accordance with U.S. GAAP, and should not be viewed as an alternative to U.S. GAAP. Furthermore, such non-GAAP measures may not be consistent with similar measures provided or used by other companies. Reconciliations for these non-GAAP measures to U.S. GAAP are provided in the Selected Financial Information and Non-GAAP Measures starting on page 12 and in the Reconciliation to Non-GAAP Measures on the Investors section of the Company's website. Non-GAAP measures included in this communication are defined below. The Company has not provided forward-looking U.S. GAAP financial measures or a reconciliation of forward-looking non-GAAP financial measures to the most comparable U.S. GAAP financial measures on a forward-looking basis because the Company is unable to predict with reasonable certainty the ultimate outcome of certain future events. These events include, among others, the impact of portfolio changes, including asset sales, mergers, acquisitions, and divestitures; contingent liabilities related to litigation, environmental and indemnifications matters; impairments and discrete tax items. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP results for the guidance period.

    Indirect costs, such as those related to corporate and shared service functions previously allocated to the Delrin® Divestiture, do not meet the criteria for discontinued operations and were reported within continuing operations in the respective prior periods. A portion of these historical indirect costs include costs related to activities the Company is undertaking on behalf of Delrin® and for which it is reimbursed ("Future Reimbursable Indirect Costs"). Future Reimbursable Indirect Costs are reported within continuing operations but are excluded from operating EBITDA as defined below. The remaining portion of these indirect costs is not subject to future reimbursement ("Stranded Costs"). Stranded Costs are reported within continuing operations in Corporate & Other and are included within Operating EBITDA.

    Adjusted Earnings is defined as income from continuing operations excluding the after-tax impact of significant items, after-tax impact of amortization expense of intangibles, the after-tax impact of non-operating pension / other post employment benefits ("OPEB") credits / costs and Future Reimbursable Indirect Costs. Adjusted Earnings is the numerator used in the calculation of Adjusted EPS, as well as the denominator in Adjusted Free Cash Flow Conversion.

    Adjusted EPS is defined as Adjusted Earnings per common share - diluted. Management estimates amortization expense in 2025 associated with intangibles to be about $590 million on a pre-tax basis, or approximately $1.08 per share.

    The Company's measure of profit/loss for segment reporting purposes is Operating EBITDA as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines Operating EBITDA as earnings (i.e., "Income from continuing operations before income taxes") before interest, depreciation, amortization, non-operating pension / OPEB benefits / charges, and foreign exchange gains / losses, excluding Future Reimbursable Indirect Costs, and adjusted for significant items. Reconciliations of these measures are provided on the following pages.

    Operating EBITDA Margin is defined as Operating EBITDA divided by Net Sales.

    Incremental Margin is the change in Operating EBITDA divided by the change in Net Sales for the applicable period.

    Significant items are items that arise outside the ordinary course of business for the Company, and beginning in the first quarter 2025, includes items for nonconsolidated affiliates, that the Company's management believes may cause misinterpretation of underlying business and investment performance, both historical and future, based on a combination of some or all of the item's size, unusual nature and infrequent occurrence. Management classifies as significant items certain costs and expenses associated with integration and separation activities related to transformational acquisitions and divestitures as they are considered unrelated to ongoing business performance. Management believes the update to the definition of significant items to include those related to nonconsolidated affiliates reflects a more accurate measure of the ongoing performance of the investment. There were no significant items associated with nonconsolidated affiliates recorded for the three-month periods ended March 31, 2025 and March 31, 2024.    

    Non-GAAP Financial Measures (continued)

    Organic Sales is defined as net sales excluding the impacts of currency and portfolio.

    Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity. As a result, Adjusted Free Cash Flow represents cash that is available to the Company, after investing in its asset base, to fund obligations using the Company's primary source of liquidity, cash provided by operating activities from continuing operations. Management believes Adjusted Free Cash Flow, even though it may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. Management notes that there were no exclusions for items that are unusual in nature and/or infrequent in occurrence for the three-month periods ended March 31, 2025 and March 31, 2014.

    Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow divided by Adjusted Earnings. Management uses Adjusted Free Cash Flow Conversion as an indicator of our ability to convert earnings to cash.

    Management believes supplemental non-GAAP financial measures including Transaction-Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each defined below) provide an integral view of information on the Company's underlying business performance during this period of transformational change. Management believes the Intended Electronics Separation represents a significant transformational change for the Company and the impact of separation-related transaction cost payments are expected to be material to the Company's financial statements. Management believes Transaction-Adjusted Free Cash Flow, which may be defined differently from other companies, is useful to investors, analysts and others to evaluate the Company's cash flow and financial performance, and it is an integral measure used in the Company's financial planning process. These non-GAAP financial measures are not intended to represent residual cash flow for discretionary expenditures since other non-discretionary expenditures, such as mandatory debt service requirements, are not deducted from the measure.

    Transaction-Adjusted Free Cash Flow is defined as cash provided by/used for operating activities from continuing operations less capital expenditures, separation-related transaction cost payments and excluding the impact of cash inflows/outflows that are unusual in nature and/or infrequent in occurrence that neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business liquidity.

    Transaction-Adjusted Free Cash Flow Conversion is defined as Adjusted Free Cash Flow excluding separation-related transaction costs divided by Adjusted Earnings.

     

    DuPont de Nemours, Inc.

    Consolidated Statements of Operations





    Three Months Ended March 31,

    In millions, except per share amounts (Unaudited)

    2025

    2024

    Net sales

    $                             3,066

    $                             2,931

    Cost of sales

    1,920

    1,918

    Research and development expenses

    137

    125

    Selling, general and administrative expenses

    369

    384

    Amortization of intangibles

    146

    149

    Restructuring and asset related charges - net

    47

    39

    Goodwill impairment charges

    768

    —

    Acquisition, integration and separation costs

    125

    3

    Equity in (losses) earnings of nonconsolidated affiliates

    (1)

    12

    Sundry income (expense) - net

    101

    38

    Interest expense

    83

    96

    (Loss) income from continuing operations before income taxes

    $                              (429)

    $                                267

    Provision for income taxes on continuing operations

    119

    84

    (Loss) income from continuing operations, net of tax

    $                              (548)

    $                                183

    (Loss) income from discontinued operations, net of tax

    (34)

    14

    Net (loss) income

    $                              (582)

    $                                197

    Net income attributable to noncontrolling interests

    7

    8

    Net (loss) income available for DuPont common stockholders

    $                              (589)

    $                                189













    Per common share data:





    (Loss) earnings per common share from continuing operations - basic

    $                             (1.33)

    $                               0.41

    (Loss) earnings per common share from discontinued operations - basic

    (0.08)

    0.03

    (Loss) earnings per common share - basic

    $                             (1.41)

    $                               0.45

    (Loss) earnings per common share from continuing operations - diluted

    $                             (1.33)

    $                               0.41

    (Loss) earnings per common share from discontinued operations - diluted

    (0.08)

    0.03

    (Loss) earnings per common share - diluted

    $                             (1.41)

    $                               0.45







    Weighted-average common shares outstanding - basic

    418.5

    422.8

    Weighted-average common shares outstanding - diluted

    418.5

    424.3

     

    DuPont de Nemours, Inc.

    Condensed Consolidated Balance Sheets



    In millions, except share amounts (Unaudited)

    March 31, 2025

    December 31, 2024

    Assets





    Current Assets





    Cash and cash equivalents

    $                               1,762

    $                               1,850

    Restricted cash and cash equivalents

    5

    6

    Accounts and notes receivable - net

    2,291

    2,199

    Inventories

    2,242

    2,130

    Prepaid and other current assets

    164

    179

    Total current assets

    $                               6,464

    $                               6,364

    Property, plant and equipment - net of accumulated depreciation (March 31, 2025 -

    $5,358; December 31, 2024 - $5,188)

    5,780

    5,768

    Other Assets





    Goodwill

    15,947

    16,567

    Other intangible assets

    5,251

    5,370

    Restricted cash and cash equivalents - noncurrent

    36

    36

    Investments and noncurrent receivables

    1,071

    1,081

    Deferred income tax assets

    245

    246

    Deferred charges and other assets

    1,187

    1,204

    Total other assets

    $                             23,737

    $                             24,504

    Total Assets

    $                             35,981

    $                             36,636

    Liabilities and Equity





    Current Liabilities





    Short-term borrowings

    $                               1,849

    $                               1,848

    Accounts payable

    1,657

    1,720

    Income taxes payable

    179

    202

    Accrued and other current liabilities

    947

    1,031

    Total current liabilities

    $                               4,632

    $                               4,801

    Long-Term Debt

    5,325

    5,323

    Other Noncurrent Liabilities





    Deferred income tax liabilities

    897

    915

    Pension and other post-employment benefits - noncurrent

    531

    523

    Other noncurrent obligations

    1,328

    1,281

    Total other noncurrent liabilities

    $                               2,756

    $                               2,719

    Total Liabilities

    $                             12,713

    $                             12,843

    Commitments and contingent liabilities





    Stockholders' Equity





    Common stock (authorized 1,666,666,667 shares of $0.01 par value each; issued

    2025: 418,498,498 shares; 2024: 417,994,343 shares)

    4

    4

    Additional paid-in capital

    47,758

    47,922

    Accumulated deficit

    (23,665)

    (23,076)

    Accumulated other comprehensive loss

    (1,263)

    (1,500)

    Total DuPont stockholders' equity

    $                             22,834

    $                             23,350

    Noncontrolling interests

    434

    443

    Total equity

    $                             23,268

    $                             23,793

    Total Liabilities and Equity

    $                             35,981

    $                             36,636

     

    DuPont de Nemours, Inc.

    Consolidated Statement of Cash Flows





    Three Months Ended March 31,

    In millions (Unaudited)

    2025

    2024

    Operating Activities





    Net (loss) income

    $                       (582)

    $                         197

    (Loss) income from discontinued operations

    (34)

    14

    Net (loss) income from continuing operations

    $                       (548)

    $                         183

    Adjustments to reconcile net income to net cash provided by operating activities:





    Depreciation and amortization

    293

    291

    Credit for deferred income tax and other tax related items

    54

    (13)

    Earnings of nonconsolidated affiliates less than (in excess of) dividends received

    11

    (7)

    Net periodic pension benefit costs

    2

    2

    Periodic benefit plan contributions

    (14)

    (19)

    Net gain on sales of assets, businesses and investments

    —

    (2)

    Restructuring and asset related charges - net

    47

    39

    Goodwill impairment charge

    768

    —

    Interest rate swap gain

    (78)

    —

    Stock based compensation

    12

    23

    Other net loss

    (6)

    (3)

    Changes in assets and liabilities, net of effects of acquired and divested companies:





    Accounts and notes receivable

    (79)

    (74)

    Inventories

    (89)

    (42)

    Accounts payable

    62

    84

    Other assets and liabilities, net

    (53)

    31

    Cash provided by operating activities - continuing operations

    $                         382

    $                         493

    Investing Activities





    Capital expenditures

    (249)

    (207)

    Proceeds and adjustments to proceeds from sales of property and businesses, net of cash divested

    —

    5

    Other investing activities, net

    2

    —

    Cash used for investing activities - continuing operations

    $                       (247)

    $                       (202)

    Financing Activities





    Purchases of common stock and forward contracts

    —

    (500)

    Proceeds from issuance of Company stock

    4

    5

    Employee taxes paid for share-based payment arrangements

    (16)

    (17)

    Distributions to noncontrolling interests

    (22)

    (20)

    Dividends paid to stockholders

    (172)

    (159)

    Cash used for financing activities - continuing operations

    $                       (206)

    $                       (691)

    Cash Flows from Discontinued Operations





    Cash used for operations - discontinued operations

    (31)

    (31)

    Cash used in discontinued operations

    $                         (31)

    $                         (31)

    Effect of exchange rate changes on cash, cash equivalents and restricted cash

    13

    (25)

    Decrease in cash, cash equivalents and restricted cash

    $                         (89)

    $                       (456)

    Cash, cash equivalents and restricted cash from continuing operations, beginning of period

    1,892

    2,803

    Cash, cash equivalents and restricted cash from discontinued operations, beginning of period

    —

    —

    Cash, cash equivalents and restricted cash at beginning of period

    $                      1,892

    $                      2,803

    Cash, cash equivalents and restricted cash from continuing operations, end of period

    1,803

    2,347

    Cash, cash equivalents and restricted cash from discontinued operations, end of period

    —

    —

    Cash, cash equivalents and restricted cash at end of period

    $                      1,803

    $                      2,347

     

    DuPont de Nemours, Inc.

    Net Sales by Segment and Geographic Region



    Net Sales by Segment and Geographic Region

    Three Months Ended

    In millions (Unaudited)

    Mar 31, 2025

    Mar 31, 2024

    ElectronicsCo

    $                                          1,118

    $                                             984

    IndustrialsCo

    1,948

    1,947

    Total

    $                                          3,066

    $                                          2,931

    U.S. & Canada

    $                                          1,059

    $                                          1,053

    EMEA 1

    553

    544

    Asia Pacific 2

    1,333

    1,216

    Latin America

    121

    118

    Total

    $                                          3,066

    $                                          2,931

     

    Net Sales Variance by Segment

    and Geographic Region

    Three Months Ended March 31, 2025



    Local Price &

    Product Mix

    Volume

    Total

    Organic

    Currency

    Portfolio / Other

    Total



    Percent change from prior year

    (Unaudited)



    ElectronicsCo

    (2) %

    16 %

    14 %

    — %

    — %

    14 %



    IndustrialsCo

    (1)

    3

    2

    (1)

    (1)

    —



    Total

    (2) %

    8 %

    6 %

    (1) %

    — %

    5 %



    U.S. & Canada

    (1) %

    1 %

    — %

    — %

    1 %

    1 %



    EMEA 1

    (1)

    5

    4

    (3)

    1

    2



    Asia Pacific 2

    (2)

    15

    13

    (1)

    (2)

    10



    Latin America

    (3)

    6

    3

    —

    —

    3



    Total

    (2) %

    8 %

    6 %

    (1) %

    — %

    5 %



    1.  Europe, Middle East and Africa.

    2.  Net sales attributed to China/Hong Kong, for the three months ended March 31, 2025 and 2024 were $587 million and $515 million, respectively.

     

    DuPont de Nemours, Inc.

    Selected Financial Information and Non-GAAP Measures







    Operating EBITDA by Segment

    Three Months Ended



    In millions (Unaudited)

    Mar 31, 2025

    Mar 31, 2024



    ElectronicsCo

    $                                         373

    $                                         295



    IndustrialsCo

    464

    439



    Corporate 1

    (49)

    (52)



    Total

    $                                         788

    $                                         682



    1. Corporate includes expenses of the Corporate function not allocated to specific business in the Company.











    Equity in Earnings of Nonconsolidated Affiliates by Segment

    Three Months Ended



    In millions (Unaudited)

    Mar 31, 2025

    Mar 31, 2024



    ElectronicsCo

    $                                             9

    $                                           10



    IndustrialsCo

    4

    9



    Corporate 1

    (14)

    (7)



    Total equity earnings included in operating EBITDA (GAAP)

    $                                           (1)

    $                                           12



    1. Corporate includes the equity interest acquired in the Delrin® Divestiture transaction.











    Reconciliation of "Income from continuing operations, net of tax" to

    "Operating EBITDA"

    Three Months Ended





    In millions (Unaudited)

    Mar 31, 2025

    Mar 31, 2024



    (Loss) income from continuing operations, net of tax (GAAP)

    $                                       (548)

    $                                         183



    + Provision for income taxes on continuing operations

    119

    84



    (Loss) income from continuing operations before income taxes

    $                                       (429)

    $                                         267



    + Depreciation and amortization

    293

    291



     - Interest income 1, 2

    18

    20



     + Interest expense 3

    82

    96



     - Non-operating pension/OPEB benefit credits 1

    3

    7



     - Foreign exchange (losses) gains, net 1

    (3)

    4



    - Significant items charge

    (860)

    (59)



    Operating EBITDA (non-GAAP)

    $                                         788

    $                                         682



    1.  Included in "Sundry income (expense) - net".

    2.  The three month period ended March 31, 2025 excludes accrued interest income earned on employee retention credits. Refer to details of significant items on page 13.

    3.  The three month period ended March 31, 2025 excludes interest rate swap basis amortization. Refer to details of significant items on page 13.



     

    Reconciliation of "Cash provided by operating activities - continuing

    operations" to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free

    Cash Flow1 and calculation of "Adjusted Free Cash Flow Conversion"

    and "Transaction-Adjusted Free Cash Flow Conversion"

    Three Months Ended

    In millions (Unaudited)

    Mar 31, 2025

    Mar 31, 2024

    Cash provided by operating activities (GAAP) 2 - continuing operations

    $                                      382

    $                                      493

    Capital expenditures

    (249)

    (207)

    Adjusted free cash flow (non-GAAP)

    $                                      133

    $                                      286

    Separation-related transaction cost payments

    79

    —

    Transaction-adjusted free cash flow (non-GAAP)

    $                                      212

    $                                      286







    Adjusted earnings (non-GAAP) 3

    $                                      432

    $                                      334

    Adjusted free cash flow conversion (non-GAAP)

    31 %

    86 %

    Transaction-adjusted free cash flow conversion (non-GAAP)

    49 %

    86 %

    1.  Adjusted Free Cash Flow and Transaction-Adjusted Free Cash Flow are calculated on a continuing operations basis for all periods presented. Refer to the definitions of Non-GAAP metrics on pages 6-7 for additional information.

    2.  Refer to the Consolidated Statement of Cash Flows included in the schedules above for major GAAP cash flow categories as well as further detail relating to the changes in "Cash provided by operating activities - continuing operations" for the three month periods noted.

    3.  Refer to page 13 for the Non-GAAP reconciliations of Net income from continuing operations available for DuPont common stockholders to Adjusted Earnings (Non-GAAP).

     

    DuPont de Nemours, Inc.

    Selected Financial Information and Non-GAAP Measures



    Significant Items Impacting Results for the Three Months Ended March 31, 2025

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported (losses) earnings (GAAP)

    $      (429)

    $      (555)

    $     (1.33)



    Less: Significant items









    Acquisition, integration & separation costs 4

    (125)

    (106)

    (0.25)

    Acquisition, integration and separation costs

    Restructuring and asset related charges - net 5

    (47)

    (37)

    (0.09)

    Restructuring and asset related charges - net

    Employee retention credit 6

    3

    3

    —

    Sundry income (expense) - net

    Goodwill impairment 7

    (768)

    (768)

    (1.83)

    Goodwill impairment charges

    Interest rate swap mark-to-market gain 8

    78

    60

    0.14

    Sundry income (expense) - net

    Interest rate swap amortization 9

    (1)

    —

    —

    Interest expense

    Income tax items 10

    —

    (27)

    (0.06)

    Provision for income taxes on continuing operations

    Total significant items

    $      (860)

    $      (875)

    $     (2.09)



    Less: Amortization of intangibles

    (146)

    (114)

    (0.27)

    Amortization of intangibles

    Less: Non-op pension / OPEB benefit credits

    3

    2

    —

    Sundry income (expense) - net

    Adjusted earnings (non-GAAP)

    $        574

    $        432

    $       1.03



     

    Significant Items Impacting Results for the Three Months Ended March 31, 2024

    In millions, except per share amounts (Unaudited)

    Pretax 1

    Net

    Income 2

    EPS 3

    Income Statement Classification

    Reported earnings (GAAP)

    $        267

    $        175

    $       0.41



    Less: Significant items









    Acquisition, integration and separation costs 11

    (3)

    (2)

    —

    Acquisition, integration and separation costs

    Restructuring and asset related charges - net 5

    (39)

    (29)

    (0.07)

    Restructuring and asset related charges - net

    Inventory write-offs 12

    (25)

    (19)

    (0.05)

    Cost of sales

    Income tax related item 13

    8

    —

    —

    Sundry Income (expense) - net

    Total significant items

    $        (59)

    $        (50)

    $     (0.12)



    Less: Amortization of intangibles

    (149)

    (115)

    (0.27)

    Amortization of intangibles

    Less: Non-op pension / OPEB benefit credits

    7

    6

    0.01

    Sundry income (expense) - net

    Adjusted earnings (non-GAAP)

    $        468

    $        334

    $       0.79



    1.     Income (loss) from continuing operations before income taxes.

    2.     Net income (loss) from continuing operations available for DuPont common stockholders. The income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

    3.     Earnings (loss) per common share from continuing operations - diluted.

    4.     Acquisition, integration and separation costs primarily related to the Intended Electronics Separation.

    5.     Includes restructuring actions and asset related charges.

    6.     Reflects the accrued interest earned on employee retention credits.

    7.     Reflects a non-cash goodwill impairment related to the Aramids reporting unit within the IndustrialsCo Segment.

    8.     Includes the non-cash mark-to-market gain related to the 2022 Swaps and 2024 Swaps and net interest settlement loss related to the 2022 Swaps.

    9.     Includes the basis amortization on the 2022 Swaps.

    10.  Reflects the income tax impact of certain internal restructurings related to the Intended Electronics Separation.

    11.  Acquisition, integration and separation costs related to the Spectrum Acquisition.

    12.  Reflects raw material inventory write-offs recorded in "Cost of Sales" in connection with restructuring actions related to plant line closures within the IndustrialsCo segment.

    13.  Reflects the impact of an international tax audit.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-reports-first-quarter-2025-results-302444617.html

    SOURCE DuPont

    Get the next $DD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    5/23/2024$96.00Market Perform → Outperform
    BMO Capital Markets
    More analyst ratings

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DuPont upgraded by BofA Securities with a new price target

      BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

      4/15/25 8:43:17 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by KeyBanc Capital Markets with a new price target

      KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

      4/14/25 8:04:47 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont upgraded by Barclays with a new price target

      Barclays upgraded DuPont from Underweight to Equal Weight and set a new price target of $89.00 from $85.00 previously

      2/13/25 8:08:02 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

      SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

      11/12/24 11:54:03 AM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

      SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

      2/13/24 4:55:53 PM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by DuPont de Nemours Inc.

      SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

      2/9/24 11:49:03 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • DuPont Completes Qnity™ Board of Directors

      Mark Blinn announced as director and chairman and Yi Hyon Paik as director WILMINGTON, Del., June 11, 2025  /PRNewswire/ -- DuPont (NYSE:DD) today announced that Mark A. Blinn and Dr. Yi Hyon Paik will become members of the future board of directors (the "Qnity Board") for Qnity Electronics, Inc., the planned, independent Electronics public company created from DuPont's intended spin-off.* Mr. Blinn will become chairman of the Qnity Board effective with the spin-off. Mr. Blinn was chief executive officer, president, and director of Flowserve Corporation until his retirement in

      6/11/25 8:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Innovators in Semiconductor Materials Named 2025 Heroes of Chemistry

      Breakthrough in Semiconductor Lithography Recognized by the American Chemical Society WILMINGTON, Del., June 10, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that 13 of its current and former scientists and engineers have been named 2025 Heroes of Chemistry by the American Chemical Society (ACS) for an innovative program that progressed semiconductor lithography. The award recognizes the collaborative development of embedded barrier layer technology, a transformative advancement in 193 nm immersion lithography that significantly improved chip fabrication processes by

      6/10/25 11:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Expands Healthcare Manufacturing Site in Costa Rica, Adding Sterile Packaging Capacity

      The 16,000-square-foot expansion enhances DuPont's global sterile operations, increases the capacity of the manufacturing site's existing medical tubing operations, and enables Costa Rica's first-ever production of sterile healthcare packaging. WILMINGTON, Del., June 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica, enabling the site to produce sterile packaging for the global medical device industry while also increasing the capacity of the site's existing medical tubing operations.

      6/5/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    SEC Filings

    See more
    • SEC Form 11-K filed by DuPont de Nemours Inc.

      11-K - DuPont de Nemours, Inc. (0001666700) (Filer)

      6/13/25 4:27:24 PM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont de Nemours Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

      5/28/25 4:58:12 PM ET
      $DD
      Major Chemicals
      Industrials
    • SEC Form SD filed by DuPont de Nemours Inc.

      SD - DuPont de Nemours, Inc. (0001666700) (Filer)

      5/15/25 11:37:22 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    See more
    • DuPont Announces Appointment of Kurt McMaken to Board of Directors

      WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

      2/21/25 4:15:00 PM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Announces Two Technology Leaders as DuPont Laureates

      Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

      10/10/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont to Acquire Donatelle Plastics Incorporated

      Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

      6/25/24 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lowery Frederick M. was granted 580 shares, increasing direct ownership by 2% to 32,579 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:10:02 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Cutler Alexander M was granted 749 shares, increasing direct ownership by 1% to 72,865 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:09:34 PM ET
      $DD
      Major Chemicals
      Industrials
    • Director Curtin Terrence R was granted 487 shares, increasing direct ownership by 2% to 30,370 units (SEC Form 4)

      4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

      6/3/25 5:08:54 PM ET
      $DD
      Major Chemicals
      Industrials

    $DD
    Financials

    Live finance-specific insights

    See more
    • DuPont Achieves 100 Percent Renewable Electricity Across its European Union Operations

      Company marks significant progress towards 2050 climate goals WILMINGTON, Del., May 27, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced 100 percent of its grid electricity is from renewable sources across its entire European Union (EU) operations, through the use of Renewable Energy Certificates (RECs). This milestone underscores the company's commitment to achieving its renewable energy goal and acting on climate stewardship as part of its 2030 Sustainability Goals, as well as marking a key step towards DuPont's commitment of net-zero carbon emissions by 2050. "At DuPon

      5/27/25 9:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Reports First Quarter 2025 Results

      Net Sales of $3.1 billion increased 5%; organic sales increased 6% versus year-ago periodGAAP Loss from continuing operations of $(548) million, includes $768 million non-cash goodwill impairment charge related to first quarter segment realignment; operating EBITDA of $788 millionGAAP EPS from continuing operations of $(1.33); adjusted EPS of $1.03Cash provided by operating activities from continuing operations of $382 million; transaction-adjusted free cash flow of $212 millionMaintaining full year 2025 financial guidance; separately providing tariff impact sensitivityWILMINGTON, Del., May 2, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the first quarter ende

      5/2/25 6:00:00 AM ET
      $DD
      Major Chemicals
      Industrials
    • DuPont Announces Regular Quarterly Dividend on Common Stock

      WILMINGTON, Del., April 29, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Board of Directors has declared a quarterly dividend of forty-one cents ($0.41) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on June 16, 2025, to holders of record of said stock at the close of business on May 30, 2025. About DuPontDuPont (NYSE:DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers a

      4/29/25 4:30:00 PM ET
      $DD
      Major Chemicals
      Industrials